何氏眼科
(301103)
| 流通市值：23.65亿 | | | 总市值：30.72亿 |
| 流通股本：1.22亿 | | | 总股本：1.58亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 305,184,437.79 | 1,092,618,730.41 | 855,274,926.4 | 560,092,655.12 |
| 营业收入 | 305,184,437.79 | 1,092,618,730.41 | 855,274,926.4 | 560,092,655.12 |
| 二、营业总成本 | 265,692,066.29 | 1,048,951,940.54 | 786,489,696.96 | 505,466,143.59 |
| 营业成本 | 170,159,791.01 | 644,789,460.4 | 497,546,294.7 | 324,503,332.43 |
| 税金及附加 | 1,492,236.39 | 5,197,904.92 | 4,099,661.75 | 2,601,626.41 |
| 销售费用 | 43,783,386.34 | 177,290,274.73 | 124,073,553.86 | 79,760,169.6 |
| 管理费用 | 44,207,155.95 | 202,484,410.09 | 149,424,009.31 | 93,836,929.78 |
| 研发费用 | 4,452,478.82 | 16,275,626.06 | 10,475,430.11 | 6,120,724.03 |
| 财务费用 | 1,597,017.78 | 2,914,264.34 | 870,747.23 | -1,356,638.66 |
| 其中:利息费用 | 1,811,137.58 | 8,768,504.3 | 6,763,696.5 | 4,606,772.4 |
| 其中:利息收入 | 865,020.14 | 7,987,948.58 | 7,543,782.72 | 6,962,143.99 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 629,139.15 | 791,429.1 | 722,074.95 | 1,869,969.56 |
| 加:投资收益 | 1,534,632.52 | 13,657,305.53 | 9,739,729.44 | 4,032,222.49 |
| 资产处置收益 | -3,616.1 | 752,206.44 | -122,027.41 | -70,009.14 |
| 资产减值损失(新) | 524,748.08 | -469,332.56 | 24,452.79 | -546,141.14 |
| 信用减值损失(新) | -378,156.48 | -4,041,874.7 | -602,274.21 | -514,600.57 |
| 其他收益 | 411,133.69 | 3,795,680.97 | 3,136,453.08 | 2,633,787.69 |
| 四、营业利润 | 42,210,252.36 | 58,152,204.65 | 81,683,638.08 | 62,031,740.42 |
| 加:营业外收入 | 20,547.44 | 1,666,239.48 | 470,530.09 | 292,761.8 |
| 减:营业外支出 | 622,123.33 | 3,783,668.21 | 1,687,115.36 | 1,256,561.98 |
| 五、利润总额 | 41,608,676.47 | 56,034,775.92 | 80,467,052.81 | 61,067,940.24 |
| 减:所得税费用 | 8,997,059.33 | 29,629,840.37 | 26,909,094.53 | 17,500,523.03 |
| 六、净利润 | 32,611,617.14 | 26,404,935.55 | 53,557,958.28 | 43,567,417.21 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 32,611,617.14 | 26,404,935.55 | 53,557,958.28 | 43,567,417.21 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 32,688,810.52 | 27,336,461.27 | 54,395,334.2 | 44,324,593.65 |
| 少数股东损益 | -77,193.38 | -931,525.72 | -837,375.92 | -757,176.44 |
| 扣除非经常损益后的净利润 | 30,811,842.56 | 10,768,532.74 | 42,428,730.55 | 37,241,675.29 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.21 | 0.17 | 0.34 | 0.28 |
| (二)稀释每股收益 | 0.21 | 0.17 | 0.34 | 0.28 |
| 八、其他综合收益 | -7,446.42 | 3,785.21 | -12,246.02 | -19,381.89 |
| 归属于母公司股东的其他综合收益 | -7,446.42 | 3,785.21 | -12,246.02 | -19,381.89 |
| 九、综合收益总额 | 32,604,170.72 | 26,408,720.76 | 53,545,712.26 | 43,548,035.32 |
| 归属于母公司股东的综合收益总额 | 32,681,364.1 | 27,340,246.48 | 54,383,088.18 | 44,305,211.76 |
| 归属于少数股东的综合收益总额 | -77,193.38 | -931,525.72 | -837,375.92 | -757,176.44 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-30 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |